Evidence map›Paper›PMID 34972189›Full record

ArticlePloS one2021

The role of Leishmania GP63 in the modulation of innate inflammatory response to Leishmania major infection.

Aretha Chan, Jose-Mauricio Ayala, Fernando Alvarez, Ciriaco Piccirillo, George Dong, David Langlais, Martin Olivier

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. An Update on Clinical and Pathogenic Spectra of Leishmaniasis.Expert reviews in molecular medicine · 2025
    Review
  7. Article
  8. Article
  9. Review
  10. Advances inPathogens (Basel, Switzerland) · 2024
    Review
  11. An update on recombinant vaccines against leishmaniasis.The Indian journal of medical research · 2024
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Aretha ChanDepartment of Microbiology and Immunology, McGill University, Montréal, QC, Canada.ORCID 0000-0003-0841-6345
Jose-Mauricio AyalaDepartment of Human Genetics, McGill Genome Centre, Montréal, QC, Canada.
Fernando AlvarezDepartment of Microbiology and Immunology, McGill University, Montréal, QC, Canada.
Ciriaco PiccirilloDepartment of Microbiology and Immunology, McGill University, Montréal, QC, Canada.
George DongDepartment of Microbiology and Immunology, McGill University, Montréal, QC, Canada.
David LanglaisDepartment of Microbiology and Immunology, McGill University, Montréal, QC, Canada.
Martin OlivierDepartment of Microbiology and Immunology, McGill University, Montréal, QC, Canada.ORCID 0000-0002-3901-6638
McGill University Health Centre · CAMcGill Genome Centre · CA

Funding

CIHR PJT-159765
6 · The paper itself

Abstract

Leishmaniasis is a disease caused by the protozoan parasite Leishmania and is known to affect millions of individuals worldwide. In recent years, we have established the critical role played by Leishmania zinc-metalloprotease GP63 in the modulation of host macrophage signalling and functions, favouring its survival and progression within its host. Leishmania major lacking GP63 was reported to cause limited infection in mice, however, it is still unclear how GP63 may influence the innate inflammatory response and parasite survival in an in vivo context. Therefore, we were interested in analyzing the early innate inflammatory events upon Leishmania inoculation within mice and establish whether Leishmania GP63 influences this initial inflammatory response. Experimentally, L. major WT (L. majorWT), L. major GP63 knockout (L. majorKO), or L. major GP63 rescue (L. majorR) were intraperitoneally inoculated in mice and the inflammatory cells recruited were characterized microscopically and by flow cytometry (number and cell type), and their infection determined. Pro-inflammatory markers such as cytokines, chemokines, and extracellular vesicles (EVs, e.g. exosomes) were monitored and proteomic analysis was performed on exosome contents. Data obtained from this study suggest that Leishmania GP63 does not significantly influence the pathogen-induced inflammatory cell recruitment, but rather their activation status and effector function. Concordantly, internalization of promastigotes during early infection could be influenced by GP63 as fewer L. majorKO amastigotes were found within host cells and appear to maintain in host cells over time. Collectively this study provides a clear analysis of innate inflammatory events occurring during L. major infection and further establish the prominent role of the virulence factor GP63 to provide favourable conditions for host cell infection.

Indexed as

AnimalsComputational BiologyExosomesFemaleHost-Parasite InteractionsInflammationLeishmaniaLeishmania majorLeishmaniasisLeishmaniasis, CutaneousMetalloendopeptidasesMetalloproteasesMiceMice, Inbred C57BLMicroscopy, Electron, TransmissionNanoparticlesglycoprotein gp63, LeishmaniaMetalloendopeptidasesMetalloproteases

Identifiers

PMID34972189
PMCPMC8719666
OpenAlexW4205249216

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.